Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03439332 : Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma
Phase
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Patients diagnosed with Glioblastoma grade IV WHO with histopathological confirmation

- Age >18 years at diagnosis

- Patients with access to the preoperative and postradiotherapy MRI studies using 1.5
Tesla (T) or 3T scanners, including: pre and post gadolinium T1-weighted MRI,
T2-weighted MRI, FLAIR MRI, Dynamic Susceptibility Contrast (DSC) T2*-weighted
perfusion, Dynamic Contrast Enhancement (DCE) T1-weighted perfusion (optional) and
Diffusion Weighted Imaging (DWI) (optional)

- WHO performance score between 0 and 2

- Patients with Karnofsky Performance Score (KPS) of = 70%

Exclusion Criteria:

- Patients with congestive heart failure within 6 months prior to study entry (New York
Heart Association = Grade 3)

- Uncontrolled or significant cardiovascular disease, including: myocardial infarction
and transient ischemic attack or stroke within 6 months prior to enrollment,
uncontrolled angina within 6 months, diagnosed or suspected congenital long QT
syndrome, any history of clinically significant ventricular arrhythmia (such as
ventricular tachycardia, ventricular fibrillation or Torsades de pointes) and
clinically significant abnormality on electrocardiogram (ECG)

- Pulmonary disease including or greater than grade 2 dyspnea or laryngeal edema, grade
3 pulmonary edema or pulmonary hypertension according to CTCAE 4.03
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03439332      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740